Published on 9/25/2003 in the Prospect News Convertibles Daily.
New Issue: UBS prices $3.57 million 0% notes linked to Pfizer
New York, Sept. 25 - UBS AG issued $3.57 million 0% notes in the enhanced appreciation securities structure linked to the common stock of Pfizer Inc., according to a filing with the Securities and Exchange Commission.
| Issuer: | UBS AG
|
| Issue: | Enhanced Appreciation Securities medium-term notes
|
| Underlying stock: | Pfizer Inc.
|
| Amount: | $3.572 million
|
| Maturity date: | Dec. 30, 2004
|
| Coupon: | 0%
|
| Price: | Par of $31.60
|
| Payout at maturity: | Par multiplied by three times gain on underlying stock capped at 21% if return is positive, otherwise par multiplied by loss on underlying stock
|
| Underwriters: | UBS Investment Bank, UBS Financial Services Inc.
|
| Pricing date: | Sept. 23
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
